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AIMS & OBJECTIVES 
 
 
1. To study the prevalence of orbital involvement in fungal sinusitis. 
2. To determine whether orbital involvement is more common in histologically  
invasive fungal sinusitis as compared to histologically non invasive fungal 
sinusitis. 
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PRESENT KNOWLEDGE AND REVIEW OF LITERATURE 
Introduction 
          Fungi are eukaryotic organisms comprising moulds, yeasts, mushrooms and 
similar organisms. More than 1,00,000 species of fungi have been described. Of 
these, only about 0.1% are recognized as human pathogens, although the number 
capable of producing human disease continues to increase.1 The incidence of 
mycotic infections and the number and diversity of pathogenic fungi have 
increased dramatically in recent years.  Although many humans are colonized by 
fungi, an intact immune system prevents subsequent infection.2 The pathogenicity 
of fungi is poorly understood. Fungi may cause disease by establishing an 
infection, elaborating toxin(s),or by inducing allergic response(s).3 
          Fungal rhinosinusitis is broadly defined as the spectrum of pathologic 
conditions associated with sinonasal inflammation that is related to the presence of 
fungi.4 Common fungal genera implicated in fungal rhinosinusitis include 
Zygomycete species (which include Rhizopus (Figure 1), Mucor, Cunninghamella 
which cause invasive fungal rhinosinusitis), hyaline moulds like Aspergillus 
species (Figure 2) and dematiaceous moulds like Alternaria, Bipolaris, Curvularia 
species (which cause allergic fungal rhinosinusitis).3 
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 Classification of fungal rhinosinusitis 
          Fungal rhinosinusitis is broadly categorized into invasive and non invasive 
types. Invasive fungal rhinosinusitis is defined by the presence of fungal hyphae in 
the mucosa, submucosa, bone or blood vessels of the paranasal sinuses. 
Invasive fungal rhinosinusitis is subdivided into: 
• Acute invasive fungal rhinosinusitis 
• Chronic invasive fungal rhinosinusitis 
• Chronic granulomatous invasive fungal rhinosinusitis 
          Non invasive fungal rhinosinusitis is defined by the absence of hyphae 
within the mucosal and other tissues of paranasal sinuses. Non invasive fungal 
rhinosinusitis is subdivided into: 
• Allergic fungal rhinosinusitis 
• Fungus ball  
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Summary of clinical features, diagnosis, radiology and treatment of 
various types of fungal sinusitis 
Allergic fungal rhinosinusitis 
          It is the most common form of fungal rhinosinusitis in warm humid 
climates.Allergic fungal rhinosinusitis was first described as a distinct clinical 
entity by Millar in 1981 and Katzenstein et al in 1983. The overall prevalence of 
allergic fungal rhinosinusitis is estimated at 5-10% of all cases of chronic 
hypertrophic sinus disease who undergo surgery.6 . In north India, it has been 
reported in upto 51% of patients with chronic rhinosinusitis.7 
          Allergic fungal rhinosinusitis represents both Gell and Coombs type 1 and 
type 3 responses. It represents type 1 response because of the elevated level of IgE 
to the specific fungus. It also represents a type 3 response because IgG antibodies 
to the specific fungus can be demonstrated in the serum. There is no cytotoxic 
event associated with these IgE antibodies as is seen with Gell and Coombs type 2 
immunologic event; therefore this is believed to be a type 3, non IgE mediated, non 
cytotoxic,antibody-dependent immunologic event.8 
          No consensus exists among rhinologists concerning diagnostic criteria for 
allergic fungal rhinosinusitis. In 1994, Bent and Kuhn described what probably are 
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the most widely accepted criteria for diagnosis. On the basis of analysis of 15 
cases, 5 common characteristics were observed. (Table 1) 
          In 1997, deShazo proposed a similar set of 5 criteria, including radiographic 
evidence of sinusitis, presence of allergic mucin (identified grossly or 
histopathologically), positive fungal stain or culture from the sinus at the time of 
surgery, absence of contributory factors (eg, diabetes mellitus, 
immunodeficiencies), and absence of fungal invasion.10 (Figure 3) The usual 
presenting symptoms include nasal obstruction, rhinorrhoea,frontal headache, 
postnasal drip, facial pain,anosmia and periorbital pain.11   
          CT scan findings include complete unilateral or bilateral opacification of 
multiple paranasal sinuses, sinus expansion and erosion of a wall of the involved 
sinus and scattered intrasinus high attenuation areas amid mucosal thickening. 
These features are noted on unenhanced CT scans.12 (Figures 4,5,6) 
          MRI scan findings in allergic fungal sinusitis are also typical. T1 weighted 
images may show high intensity or low intensity or intermediate signal intensity 
whereas T2 weighted images show characteristic low signal intensity or signal void 
due to the high concentration of various metals such as iron, magnesium and 
manganese concentrated by the fungi and also due to the high protein and low free 
water content of the allergic mucin.13A protein concentration above 28% can lead 
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to decreased signal intensity in both T1 and T2 weighted images because of  
increased cross-linking and slower macromolecular motion.14 On gadolinium 
contrast, T1 and T2 weighted images show peripheral high signal intensity.14 
Fungus Balls 
          Fungus balls are composed of matted fungal hyphae in the absence of 
allergic mucin. Earlier, these were referred to as aspergilloma and mycetoma. They 
are usually found in only one sinus, most frequently the maxillary followed by the 
sphenoid.4 Ethmoid sinus involvement is rare and when it occurs, it is frequently 
contiguous with the maxillary sinus. Frontal sinus involvement is uncommon. 
Geographically, these lesions are commonly found in France. 
          The age range for patients with fungus balls is 18 to 86 years. (Mean age 
59.5 years) There is a female preponderance of 2:1.4 Clinical presentation is 
typically non specific and is identical to that of chronic sinusitis. In decreasing 
frequency, nasal congestion, obstruction, discharge, fever, cough, blurred vision, 
cacosmia and ocular symptoms can be present. The symptoms may be present for 
months or even years. Nasal endoscopy may reveal minimal evidence of sinusitis. 
10% of patients have polyps.15. 
          The most likely cause of fungus balls is the persistence of fungal spores 
within the nasal cavity or entrance of spores into the sinus and subsequent 
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germination and growth. The host is immunocompetent but if immunocompromise 
develops, then this non invasive manifestation may become invasive and life 
threatening.16 
          Paranasal sinus CT scan findings in this disease include  opacification of the 
affected sinus with a rim of soft tissue attenuation along the bony walls of the 
involved sinus. Several well defined hyperdense foci may be detected.4  (Figure 7) 
          MRI shows hypointense T1 and T2 weighted images. Fungal cultures are 
frequently negative. Grossly, they appear as either soft moist clumps of debris or 
firm gritty and crumbly balls. The colour may vary from white, yellow, 
greenish,tan brown and black. Common etiologic organisms include Aspergillus 
fumigatus, Pseudallescheria boydii, Alternaria or other species. The histological 
features are typical.(Table 2, Figure 8) 
Acute invasive fungal Rhinosinusitis 
          Acute fulminant invasive rhinosinusitis is a disorder which occurs in patients 
with an impaired neutrophilic response secondary to disorders like poorly 
controlled type 1 diabetes mellitus, AIDS, hemochromatosis, aplastic anemia, 
iatrogenic immunosuppression, organic transplantation or hematologic malignancy 
(Table 3). Absolute neutrophil counts below 500 cells/mL are strongly correlated 
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with the development of invasive fungal disease.17A number of clinical conditions 
may be associated with acute invasive fungal sinusitis.  
          The disease has a rapid onset and progression.Typically, the symptoms will 
be of less than 4 weeks duration. In the absence of treatment, the disease is rapidly 
fatal in 50-80% of the patients secondary to invasion of the orbit and intracranial 
cavity.17 
           Medical advancements have prolonged the survival of 
immunocompromised patients which in turn has increased the population at risk 
for developing invasive fungal rhinosinusitis. The disease is thought to originate in 
the nasal cavity in most cases before extending into the paranasal sinuses or deeper 
body compartments such as the orbit or intracranial cavity.  
          The initial symptoms are often subtle and a high index of suspicion should 
be there while managing an at risk patient. The most common symptom in upto 
90% of patients is fever of unknown origin that has not responded to 48 hours of 
appropriate broad spectrum intra venous antibiotics. Local symptoms like facial 
and periorbital pain, nasal congestion and rhinorrhoea, and headache are variably 
present in 20-60% of patients. Late signs and symptoms include loss of visual 
acuity, ophthalmoplegia, proptosis, change in mental status,focal neurologic signs 
and seizure.17 
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          The most consistent finding on nasal endoscopy is an alteration in the 
appearance of normal pale pink nasal mucosa. White discoloration indicates tissue 
ischemia secondary to angiocentric invasion whereas black discoloration signifies 
tissue necrosis. Mucosal abnormalities are seen most commonly affecting the 
middle turbinate followed by the septum, palate and inferior turbinate. Decreased 
mucosal bleeding or sensation also may be noted because these may be signs of 
fungal invasion.17 
          CT scan of the paranasal sinuses shows minimal abnormalities in the early 
stages of the disease. Often, only mild mucosal thickening may be evident in the 
affected sinus(Figure 9).This may be associated with features of cavernous sinus 
thrombosis or dural enhancement suggesting intracranial invasion. Contrast studies 
may show periorbital or dural inflammation. 
          Whereas CT is better to assess bone changes,MR imaging is superior in 
evaluating intracranial and intraorbital extension of the disease.Inflammatory 
changes in the orbital fat and extraocular muscles and resulting proptosis herald 
intraorbital invasion by the fungal infection.Leptomeningeal enhancement may be 
seen with intracranial invasion and is subtle in the initial stages.With progressive 
infection, adjacent cerebritis, granulomas and cerebral abscess formation may be 
encountered.Intracranial granulomas appear hypointense on T1 and T2 weighted 
images with minimal enhancement on contrast enhanced images.13 Silverman and 
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Mancuso18 noted that soft tissue infiltration of periantral fat planes around the 
maxillary sinus provides early evidence of invasive fungal sinusitis. 
          With rare exceptions, the disease usually starts in the sino-nasal 
tissues(limited sino-nasal disease), progresses to the orbits(limited rhino-orbital 
disease) and finally affects the central nervous system (rhino-orbito-cerebral 
disease)19.Infection gains entrance to the central nervous system through the orbital 
roof, orbital apex and cribriform plate.Internal carotid artery,middle cerebral 
artery, ciliary artery, retinal artery,cavernous sinus are all subject to the 
progression of the disease. Histopathological features are typical (Table 4, 
Figures 10,11) 
Chronic invasive fungal sinusitis  
          This disease is characterized by a chronic course with slow disease 
progression and invasion of the mucosa, submucosa, blood vessels or bone.5 It 
usually occurs in healthy individuals, though many have a previous history of 
chronic rhinosinusitis type symptoms,upper respiratory allergies or nasal 
polyposis.18 
          Symptoms directly related to the invasive disease may take months or years 
to appear and may only develop once the orbit or skull base are involved. Erosion 
into orbit may produce proptosis. Invasion of maxillary floor may produce palatal 
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erosions. Erosion of cribriform plate may produce chronic headache, seizures, 
decreased mental status or focal neurologic deficits. Extension through the 
sphenoid sinus may produce cavernous sinus thrombosis or orbital apex 
syndrome.18 Intranasally, there may be polypoid mucosa or a soft tissue mass that 
can be mucosa covered or ulcerated. Crusting or black discoloration of the mucosa 
may be seen in some patients. 
          Chronic invasive fungal sinusitis has specifically been associated with 
Aspergillus, Mucor, Alternaria, Curvularia, Bipolaris, Candida, Drechslera, 
Sporothrix and Pseudallescheria boydii.18 
          Radiologically, a hyperattenuating soft tissue collection is seen in non contrast 
CT within one or more of the paranasal sinuses. There may be destruction of sinus 
walls and extension beyond sinus confines. There is decreased signal intensity on 
T1 weighted MR images and markedly decreased signal intensity on T2 weighted 
images.13 Histopathologically, characteristic features are seen (Table 5) and it has 
to be differentiated from acute invasive (Table 6). 
Chronic granulomatous invasive fungal sinusitis 
          This is primarily found in Sudan and Southeast Asia, usually caused by 
Aspergillus flavus.20,21 However, there have been a few reports from India and 
Pakistan.22 Most patients are immunocompetent. It is characterized by non 
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caseating granulomas in the tissue and invasion of the mucosa, submucosa, blood 
vessels or bone. Proptosis is the most common presenting complaint.18 Clinically 
patients present with a nasal, sinus and/or orbital mass. Grossly it may appear as 
firm rubbery hard fibrous grayish white masses with an irregular surface. 
Histological features are typical (Table 7, Figure 12)  
          Veress et al have described 3 variants: Proliferative (granulomatous 
pseudotubercles in a fibrous tissue stroma), Exudative-necrotizing (with prominent 
foci of necrosis), and a mixed form.23 
          Unless removed surgically, the resulting fibrous fungal mass may spread to 
orbit, dura and brain.5 
Pathways of orbital spread in fungal sinusitis 
          The orbit is the adjacent anatomic site most likely to be affected by extension 
of the disease, with routes of access provided through erosion of the lamina 
papyracea, superior wall of the maxillary sinus and floor of the frontal sinus.24 
          Visual loss as a consequence of acute inflammatory paranasal disease is a 
rare but well recognized complication first noted in the literature in 1893. A 
classification system for orbital complications of paranasal sinuses was presented 
by Hubert in 1937 and further refined by Chandler in 1970. 
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Chandler 25 classified the orbital complications of sinusitis into 5 groups. 
1.Preseptal Cellulitis where the eyelids are swollen but the extra ocular movements 
are intact and the vision is normal. 
2.Orbital Cellulitis is characterized by a more diffuse orbital edema with or without 
impaired extra ocular movements. Vision is usually normal. 
3.Sub periosteal abscess is characterized by proptosis and impaired extra ocular 
movements. 
4.Orbital abscess is characterized by severe exophthalmos, chemosis, complete 
ophthalmoplegia. Visual impairment is common. 
5.Cavernous sinus thrombosis. 
          The prognosis and pathogenesis of the visual loss appears to differ 
depending on the underlying nasal pathology.26 The ethmoid sinus is separated 
from the medial wall of orbit by the paper thin lamina papyraceae which is the 
weakest part of the medial wall. It is perforated by numerous foramina for nerves 
and blood vessels. Congenital or other dehiscences of the lamina papyraceae 
expose the orbital contents to direct extension of sinusitis.26 In addition, superior 
and inferior ophthalmic veins are valveless, allowing direct communication 
between nose, ethmoid sinuses, face, orbit and cavernous sinus.26 
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          Orbital periosteum/periorbita is the only soft tissue barrier between the 
paranasal sinuses and the orbital contents. It is composed of fibrous tissue that can 
be elevated easily off the underlying bone. Orbital septum is a reflection of the 
periorbita at the margins of the orbit. It passes centrally to fuse with the tarsal 
plates. Periorbita prevent infection from passing through the eyelids into the 
orbit.26 
          The periosteum of the orbit functions as a barrier between the paranasal 
sinuses and the orbital contents, but is potentially breached by multiple anatomic 
pathways. The ethmoidal artery foramina, dehiscences in the lamina papyracea and 
thin floor of the frontal sinus, as well as valveless ethmoidal veins provide routes 
for extension of infection to the orbit.26 Orbital involvement primarily results from 
a thrombophlebitis and interference with venous drainage of orbital contents. The 
combination of phlebitis and direct entry of the pathogen into perivascular 
structures results in both infectious and inflammatory changes.26 Extension of the 
disease into the orbit or the intracranial cavity results from a natural progression of 
disease once the erosion occurs.24 
          Proposed mechanisms for visual loss associated with sinonasal disease 
include 1) optic neuritis as a result of an adjacent inflammatory process, 2) venous 
congestion of the optic nerve due to incrceasing intraorbital pressure or 
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thrombophlebitis within the valveless orbital veins, or 3) increased intraorbital 
pressure resulting in occlusion of the central retinal artery.26 
          Orbital involvement is indicated by loss of vision, ocular motility restriction, 
proptosis, external and internal ophthalmoplegia, conjunctival pallor, chemosis and 
central retinal artery occlusion. Some studies have shown that orbital 
complications are seen more often in invasive fungal sinusitis than in the non 
invasive form.26 
          Radiological features in fungal sinusitis that suggest orbital involvement 
include erosion of the medial orbital margin, obliteration of periorbital fat and 
features of orbital cellulitis/abscess formation. Inflammatory changes in the orbital 
fat and extraocular muscles and resulting proptosis herald intraorbital invasion by 
the fungal infection.  
          Whereas CT scan is better for assessment of bone changes, MR imaging is 
superior in evaluating intracranial and intraorbital extension of the disease.27 Bone 
erosion alone should not be interpreted as evidence of fungal invasion.24 
Orbital manifestations in fungal rhinosinusitis 
          In mucormycosis, spread of infection into the orbit results in orbital cellulitis, 
loss of extraocular movement function and proptosis with failing vision. Ultimately 
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there is full blown orbital apex syndrome reflecting the destruction of cranial nerves 
3,4 and 6, ophthalmic branch of trigeminal nerve and blood vessels traversing the 
optic foramen and superior orbital fissure.28 Some patients present with ptosis and 
proptosis(Figures 13,14) 
          Clinical features include complete ophthalmoplegia, fixed dilated pupil, 
corneal and upper facial anaesthesia, chemosis and conjunctival haemorrhage and 
blindness resulting from retinal artery thrombosis caused by direct invasion of 
fungal elements. The fungi can also invade cavernous sinus and internal carotid 
artery causing thrombosis and cerebral infarction as a result of vascular 
compromise.28 
          Bhadada et al29 published a series of 6 patients with Type 1 Diabetes 
Mellitus with mucormycosis. Proptosis and ptosis were the most common 
symptoms noted. 5 patients had ophthalmoplegia and vision loss. On imaging 
orbital involvement was seen in all patients except one. Maxillary sinus was the 
most commonly involved sinus followed by ethmoid, frontal and sphenoid.  
          CT scan or MRI scan can demonstrate the extent of the disease. CT is better 
to assess bone changes and MR imaging is superior in evaluating intraorbital and 
intracranial extension. Orbital involvement may be seen as an intra orbital mass, 
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intraorbital muscle involvement, cavernous sinus extension or optic nerve 
compression. Lamina papyracea may be breached.2 
          In allergic fungal rhinosinusitis,the disease may extend into the orbit and 
compress the optic nerve causing proptosis and progressive vision loss. It may also 
present as telecanthus and  malar flattening.30.The orbital symptoms are quite 
responsive to surgical debridement and steroids.31Radiologically, there may be 
expansion into the orbit, displacement of intraorbital contents and demineralization 
of bone.(Figure 15) 
          Fungus balls can produce a compressive optic neuropathy when they involve 
the posterior ethmoid or sphenoid sinuses.31Radiologically, there may be evidence 
of expansion into the orbit. Bony destruction may also be seen.16 
          Granulomatous invasive fungal rhinosinusitis is associated with other cranial 
nerve palsies but may present with an isolated optic neuropathy mimicking 
idiopathic retrobulbar neuritis with pain on extra ocular movements.31 It may cause 
progressive exophthalmos and loss of vision can be the presenting complaint. 
Isolated sphenoid sinusitis can lead to involvement of optic nerve in the optic 
canal. 32 Radiologically, there may be erosion of the orbital walls with invasion of 
the orbital soft tissues.13 (Figures 16,17,18,19,20) 
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MATERIALS AND METHODS 
a) Study design: 
          This was a descriptive study in which data collection was performed both 
prospectively and retrospectively.  
b) Subjects: 
          Patients with a diagnosis of fungal sinusitis as confirmed by fungal smear 
and/ culture managed in the Department of ENT, Christian Medical 
College,Vellore. 
c) Exclusion criteria: 
          Patients who did not have a CT or MRI scan of the paranasal sinuses and 
those patients with sinusitis in whom fungus was not identified either by histology 
or fungal culture. 
d) Informed Consent: 
          For all prospective patients, informed consent was taken in the patient’s 
language. The consent form and the patient information sheet are attached as 
Appendix A.  
e) Methods: 
          In the prospective part, all patients with a diagnosis of fungal sinusitis as 
confirmed by histopathology and fungal smear and/ culture presenting in the Out 
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patient section of the Department of ENT from April 2008 to October 2009 were 
included. A detailed ear, nose, throat examination including rigid nasal endoscopy 
was performed for all patients as per the proforma (attached as Appendix B). A 
complete eye examination was performed by the Ophthalmologist. For all 
patients,the diseased nasal mucosa was sent for histopathological examination and 
for fungal smear and culture. Post operatively, rigid nasal endoscopy was 
performed for all patients at 1 week. Thereafter, patients with non invasive fungal 
sinusitis or those with invasive fungal sinusitis on oral medication were followed 
up every 3 months till 1 year then at 6 monthly intervals for 2 years. Patients 
receiving Amphotericin B for invasive fungal sinusitis were followed up every 
month till conclusion of therapy, then at 3 monthly intervals for a year and at 6 
monthly intervals for 2 years. 
          In the retrospective series, patients with a diagnosis of fungal sinusitis as 
confirmed by histopathology and fungal smear and/ culture managed in the 
Department of ENT from 1998 to 2008 having complete medical records were 
included.  
          Institutional Review Board approval was obtained prior to commencing the 
study.     The presence of co-morbidities was noted. Information regarding 
laboratory tests, histopathological examination, fungal smear, culture and 
sensitivity results and treatment given were recorded till the treatment was 
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complete. Specific features on CT scanning +/- MRI scanning of the paranasal 
sinuses were noted. 
f) Sample size: 
          The prevalence of orbital involvement in allergic fungal sinusitis has been 
determined in a previous study to be 56% 21 and in acute invasive sinusitis to be 
67% 19.  Sample size was calculated as per the former study.  
Formula for calculating sample size Æ  n = (z@/2)2 PQ/d2 
n (number of subjects) 
z@/2 = 1.96 (a constant) 
P = 56  
Q = 100 – P = 44 
d(Precision) = 10 
n = (z@/2)2 PQ/d2 = 1.962 x 50 x 50/102 = 95. 
h) Statistical Analysis: 
 Categorical variables are presented using frequencies and percentages. 
Association between categorical variables was assessed using Chi-square test and 
Fisher’s exact test. P-value < 0.05 is considered statistically significant. All 
statistical analyses were performed using SPSS 16.0. 
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RESULTS AND ANALYSIS 
 
          Of the100 patients included in the study, 34 patients had invasive fungal 
rhinosinusitis and 66 had non invasive fungal rhinosinusitis. 
1.Invasive fungal rhinosinusitis 
Table 1. Types of invasive fungal rhinosinusitis    (n=34) 
        Type Number of 
patients 
Acute invasive 25 
Chronic granulomatous invasive 8 
Chronic invasive 1 
Total 34 
 
Invasive fungal rhinosinusitis includes patients with acute invasive, chronic 
invasive and chronic granulomatous invasive fungal rhinosinusitis. The 
demographic and orbital signs and symptoms and radiological findings of each 
were considered together and separately. 
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Table 2.Demographic Table     (n=34) 
Age range Male Female Total 
<15 3 0 3 (8.8%) 
16-25 1 0 1 (2.9%) 
26-40 7 1 8 (23.5%) 
41-55 9 5 14 (41.2%) 
>55 5 3 8 (23.5%) 
Total 25 (73.5%) 9 (26.5%)  
 
64.7% of the patients were over 41 years. Age range was 7 to 78 years with the 
mean age 47.43 years. 25 (73.5%) of the patients were male. 
Table 3. Ophthalmic  symptoms    (n=34) 
 Periorbital
Swelling 
Decrease
d vision 
Diplopia Periorbital
Pain 
Durati
on 
mean 
Range 
Right 12 (35.3%) 10(29.4%) 7 (20.6%) 10(29.4%) 100 
days 
2 days – 
3 years Left 11(32.3%) 9(26.5%) 8 (23.5%) 11 (32.3%) 
Bilateral 1 (2.9%) 1 (2.9%) 0 0 
Total 23(67.6%) 20(58.8%) 15 (44.1%) 21(61.7%) 
 
23 (67.6 %) of the patients had ocular symptoms. Periorbital swelling and pain 
were the most common symptoms. Decreased vision was seen in 20 (58.8%) 
patients. The mean duration of symptoms was 100 days. 
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Table 4. Ophthalmological examination   (n=34) 
 Proptosis Impaired 
vision 
EOM 
restriction
Optic 
Atrophy 
Papilloedema 
Right 12(35.3%) 10(29.4%) 12(35.3%) 8(23.5%) 1 (2.9%) 
Left 9 (26.5%) 8 (23.5%) 9 (26.5%) 6(17.6%) 1 (2.9%) 
Total 21(61.8%) 18 (53%) 21(61.8%) 14(41.2%) 2 (5.8%) 
 
 Proptosis was the most common sign with 61.8% of patients having it. Optic 
atrophy was seen in 14 (41.2%) and impaired vision was seen in 18 (53.5%) 
patients. Papilloedema was seen in 2 (5.8 %) of patients. 
 
 
 
Table 5.Radiology    (n=34) 
 
13(38.3%)  patients had erosion of the lamina papyracea and 7(20.6%)  had 
intraocular mass. 5 (14.7 %) had intra ocular muscle involvement. 4(11.8%) had 
optic nerve involvement. 
 
 
 
 
 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Right 9 (26.5%) 2 (5.8%) 4 (11.8%) 4 (11.8%) 4 (11.8%) 4 (11.8%) 
Left 4 (11.8%) 1 (2.9%) 1 (2.9%) 3 (8.8%) 1 (2.9%) 0 
Bilateral 0 0 0 0 0 0 
Total 13 (38.3%) 3 (8.8%) 5 (14.7%) 7 (20.6%) 5 (14.7%) 4 (11.8%) 
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1a) Acute invasive fungal rhinosinusitis  
  
Table 1.Demographic Table     (n=25) 
Age range Male Female Total 
<15 3 0 3 (12%) 
16-25 0 0 - 
26-40 5 1 6 (24%) 
41-55 5 4 9 (36%) 
>55 4 3 7 (28%) 
 
16 patients(64%) were above 41 years. Age range was 7 to 78 years with the mean 
age 45.28 years. 17 (72%) of the patients were male. 
 
Table 2. Ophthalmic  symptoms    (n=25) 
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital
Pain 
Duration 
mean 
Range 
Right 7 (28%) 5 (20%) 4 (16%) 7(28%) 10.82 2-21 
days Left 9(36%) 7(28%) 6(24%) 9 (36%) 
Bilateral 1 (4%) 1 (4%) 0 0 
Total 17(68%) 13(52%) 10 (40%) 16(64%) 
 
17 (68%) of the patients had ocular symptoms. Periorbital swelling and pain were 
the most common symptoms. Left side was more affected than right side. The 
mean duration of symptoms was 10.82 days. 
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Table 3. Ophthalmological examination     (n=25) 
 Proptosis Impaired 
vision 
EOM 
restriction
Optic 
Atrophy 
Papilloedema 
Right 7 (28%) 5 (20%) 7 (28%) 3 (12%) 1 (4%) 
Left 7 (28%) 6 (24%) 6 (24%) 4 (16%) 1 (4%) 
Total 14 (56%) 11 (44%) 13 (52%) 7 (28%) 2 (8%) 
 
 Proptosis (56%)was the most common sign . Optic atrophy was seen in 7 (28%) 
and impaired vision was seen in 44% patients. Papilloedema was seen in 8 % of 
patients. 
Table 4. Radiology    (n=25) 
 
8 (32%) patients had erosion of the lamina papyraceae and 5 had an intraocular 
mass (20%). No patient had optic nerve compression. 
 
 
 
 
 
 
 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Right 4 (16%) 0 2 (8%) 2 (8%) 1 (4%) 0 
Left 4 (16%) 1 (4%) 1 (4%) 3 (12%) 0 0 
Bilateral 0 0 0 0 0 0 
Total 8 (32%) 1 (4%) 3 (12%) 5 (20%) 1 (4%) 0 
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1b)Chronic granulomatous invasive fungal rhinosinusitis  
 
Table 1. Demographic Table    (n=8) 
Age range Male Female Total 
<15 0 0 0 
16-25 1 0 1 (12.5%) 
26-40 2 0 2 (25%) 
41-55 3 1 4 (50 %) 
>55 1 0 1 (12.5%) 
Total 7 1 8 
 
62.5% patients were over 41years. Age range was 20 to 58 years with the mean age 
41.5 years. Most of the patients were male. 
Table 2. Ophthalmic  symptoms     (n=8) 
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital
Pain 
Duration 
mean 
Range 
Right 5 (62.5%) 5 (62.5%) 3(37.5%) 3 (37.5%) 168.6 
days 
5 days- 
3 years Left 1 (12.5%) 1(12.5%) 1(12.5%) 1(12.5%) 
Total 6(75%) 6 (75%) 4 (50%) 4 (50%) 
 
75%  patients had periorbital swelling. 75% had decreased vision. Right side was 
more affected than left side. The mean duration of symptoms was 168.6 days. 
Table 3. Ophthalmological examination   (n=8) 
 Proptosis Impaired 
vision 
EOM 
restriction
Optic 
Atrophy 
Right 5 (62.5%) 5 (62.5%) 5 (62.5%) 5 62.5%)
Left 1 (10%) 1 (10%) 1 (10%) 1 (10%) 
Total 6 (72.5%) 6 (72.5%) 6 (72.5%) 6(72.5%)
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Proptosis, impaired vision & extra ocular movement restriction were seen in 5 
(62.5%) of patients. Optic atrophy was seen in a high proportion (72.5%) patients. 
 
Table 4. Radiology    (n=8) 
 
Four(50%) patients had erosion of the lamina papyracea and 2 had an intraocular 
mass (25%) Three patients had intraocular muscle involvement (37.5%) and 4 
(50%) had optic nerve compression.  
1c) Chronic invasive fungal rhinosinusitis  (n=1)  
The patient was a 55 year old male. 
Table 1. Ophthalmic  symptoms     (n=1) 
 
 
 
He presented with left sided periorbital swelling and pain, diplopia and decreased 
vision of 4 months duration. 
 
 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Right 4 (50%) 2 (25%) 2 (25%) 2 (25%) 3 (37.5%) 4 (50%) 
Left 0 0 0 0 0 0 
Bilateral 0 0 0 0 0 0 
Total 4 (50%) 2 (25%) 2 (25%) 2 (25%) 3 (37.5%) 4 (50%) 
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital
Pain 
Duration  
Left Present Present Present Present 4 months 
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Table 2. Ophthalmological examination   (n=1) 
 
 
 
 
On examination he had proptosis, ophthalmoplegia and optic atrophy. 
 
Table 3. Radiology    (n=1) 
 
 
He had erosion of right lamina papyracea and left intra ocular muscle involvement 
 
 
Patients with acute invasive fungal rhinosinusitis were compared with 
those with chronic invasive and chronic granulomatous invasive 
fungal rhinosinusitis and tests of significance were performed to see 
whether there was any significant difference in terms of orbital 
involvement. Orbital involvement was considered as clinical and 
radiological involvement. 
 
 
 
 Proptosis Impaired 
vision 
EOM 
restriction 
Optic 
Atrophy 
Left Present Present Present Present 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor 
of orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Right 1 0 0 0 0 0 
Left 0 0 0 0 1 0 
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Comparison between acute invasive fungal rhinosinusitis and 
chronic invasive & chronic granulomatous invasive fungal 
rhinosinusitis  
Table 1. Ophthalmic  symptoms                             
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital 
Pain 
Acute    
(n=25) 
17 (68%) 13 (52%) 10 (40%) 16 (64%) 
Chronic    
(n=9) 
8 (88.9%) 7 (77.8%) 5 (55.6%) 5 (55.6%) 
P value .386 .250 .462 .704 
 
There was no significant difference in orbital symptoms between patients with 
chronic invasive and chronic granulomatous fungal rhinosinusitis and acute 
invasive fungal rhinosinusitis. 
Table 2. Ophthalmological examination 
 
 
 
 
 
 
Although there was no significant difference in orbital signs like proptosis, 
impaired vision and ophthalmoplegia between patients with acute invasive and 
patients with chronic invasive and chronic granulomatous invasive fungal 
 Proptosis Impaired 
vision 
EOM 
restriction 
Optic Atrophy/ 
Papilloedema 
Acute 
(n=25) 
14 (56%) 11 (44%) 13 (52%) 9 (36%) 
Chronic 
(n=9) 
7 (77.8%) 7 (77.8%) 7 (77.8%) 7 (77.8%) 
P value .427 .125 .250 .052 
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rhinosinusitis, optic atrophy/papilloedema was significantly  more in chronic 
invasive  and chronic granulomatous invasive fungal rhinosinusitis. 
Table 3.Radiology 
 
Radiologically, intraocular muscle involvement and optic nerve compression were 
significantly more in chronic invasive  and chronic granulomatous invasive fungal 
rhinosinusitis as compared to acute invasive fungal rhinosinusitis. 
2.Non invasive fungal rhinosinusitis 
 
Table 1. Types of non invasive fungal rhinosinusitis 
        Type Number of 
patients 
Allergic fungal  54 
Fungus ball 12 
Total 66 
 
Non invasive fungal rhinosinusitis includes patients with allergic fungal 
rhinosinusitis and those with fungus ball. The demographic and orbital signs and 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Acute 
(n=25) 
8 (32%) 1 (4%) 3 (12%) 5 (20%) 1 (4%) 0 
Chronic 
(n=9) 
5 (55.6%) 2 (22.2%) 2 (22.2%) 2 (22.2%) 4 (44.4%) 4 (44.4%) 
P value .254 .164 .591 1.000 .012 .003 
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symptoms and radiological findings of each were considered separately and 
together. 
Table 2.Demographic Table   (n=66) 
Age range Male Female Total 
<15 0 0 0 
16-25 3 5 8 (12.1%) 
26-40 5 15 20(30.3%) 
41-55 8 15 23 (34.8%) 
>55 4 11 15 (22.7%) 
Total 20 (30.3%) 46 (69.7%) 66 
 
38 (57.5%) of the patients were above 41 years. Age range was 16 to 72 years with 
the mean age 48 years. 46 (69.7%) of the patients were female. 
Table 3. Ophthalmic  symptoms    (n=66) 
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital
Pain 
Duration 
mean 
Range 
Right 3 (4.5%) 0 0 1(1.5%) 8 months 8 days 
– 2 
years 
Left 3(4.5%) 2(3%) 0 3 (4.5%) 
Bilateral 2(3%) 1 (1.5%) 1 (1.5%) 1(1.5%) 
Total 8(12.1%) 3 (4.5%) 1 (1.5%) 5(7.6%) 
 
8 (12.1%) of the patients had ocular symptoms. Periorbital swelling and pain were 
the most common symptoms. 3 (4.5%) patients had decreased vision. The mean 
duration of symptoms was 8 months. 
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Table 4. Ophthalmological examination   (n=66) 
 Proptosis Impaired 
vision 
EOM 
restriction 
Optic 
Atrophy
Papilloedema 
Right 3 (4.5%) 0 0 0 0 
Left 2 (3%) 4 (6.1%) 3 (4.5%) 2 (3%) 0 
Bilateral 1 (1.5%) 0 0 0 0 
Total 6 (9%) 4 (6.1%) 3 (4.5%) 2 (3%) 0 
 
 Proptosis(9%) was the most common sign.Optic atrophy was seen in 2 (3%) and 
impaired vision was seen in 4 (6.1%) patients. None had papilloedema.  
Table 5. Radiology    (n=66) 
17(25.7%)  of the patients had erosion of the lamina papyracea and 11 (16.7%) had 
intraocular mass. 3(3%) had optic nerve compression. 
2a) Allergic fungal rhinosinusitis  
Table 1.Demographic Table     (n=54) 
Age range Male Female Total 
<15 0 0 0 
16-25 3 5 8 (14.8%) 
26-40 5 14 19(35.2%) 
41-55 7 13 20 (37%) 
>55 1 6 7 (13%) 
Total 16 38 54 
 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Right 8 (12.1%) 1 (1.5%) 0 5 (7.6%) 2 (3%) 1 (1.5%) 
Left 8(12.1%) 4 (6.1%) 1(1.5%) 5 (7.6%) 0 2(3%) 
Bilateral 1 (1.5%) 0 0 1 (1.5%) 0 0 
Total 17 (25.7%) 5 (7.6%) 1 (1.5%) 11 (16.7%) 2 (3%) 3 (3%) 
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37% of the patients were between the ages of 41 and 55 years. Age range was 16 to 
67 years with the mean age 39.13 years. 38 (70.3%) of the patients were female. 
Table 2. Ophthalmic  symptoms    (n=54) 
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital
Pain 
Duration 
mean 
Range 
Right 3 (5.5%) 0 0 1(1.8%) 8 months 8 days 
– 2 
years 
Left 3(5.5%) 1(1.8%) 0 2 (3.6%) 
Bilateral 2(3.7%) 1 (1.8%) 1 (1.8%) 1(1.8%) 
Total 8(14.8%) 2 (3.7%) 1 (1.8%) 4(7.4%) 
 
8 (14.8%) of the patients had ocular symptoms. Periorbital swelling and pain were 
the most common symptoms. The mean duration of symptoms was 8 months. 
Table 3. Ophthalmological examination    (n=54) 
 Proptosis Impaired 
vision 
EOM 
restriction 
Optic 
Atrophy
Papilloedema 
Right 3 (5.5%) 0 0 0 0 
Left 2 (3.6%) 3 (5.5%) 2 (3.6%) 1 (1.8%) 0 
Bilateral 1 (1.8%) 0 0 0 0 
Total 6 (11.1%) 3 (5.5%) 2 (3.7%) 1 (1.8%) 0 
 
 Proptosis was the most common sign (11.1%). Optic atrophy was seen in 1 and 
impaired vision was seen in 3 (5.5%) patients.  
Table 4. Radiology    (n=54) 
 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Right 7 (13%) 1 (1.8%) 0 5 (9.25%) 2 (3.6%) 1 (1.8%) 
Left 8(14.8%) 4 (5.5%) 1(1.8%) 5 (9.25%) 0 2(3.6%) 
Bilateral 0 0 0 0 0 0 
Total 15 (27.8%) 5 (7.3%) 1 (1.8%) 10 (18.5%) 2 (3.6%) 3 (5.4%) 
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15 (27.8%) patients had erosion of the lamina papyracea and 10 (18.5%) had 
intraocular mass. 3(5.4%) had optic nerve compression. 
 
2b) Fungus Ball  
Table 1. Demographic Table     (n=12) 
Age range Male Female Total 
<15 0 0 0 
16-25 0 0 0 
26-40 0 1 1 (8.3%) 
41-55 1 2 3 (25%) 
>55 3 5 8 (66.7%) 
Total 4(33.3%) 8(66.7%)  
 
66.7% of the patients were above the age of 55 years. Age range was 39 to 72 
years with the mean age 57 years. 8 (66.7%) of the patients were male. 
Table 2. Ophthalmic  symptoms     (n=12) 
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital
Pain 
Right 0 0 0 0 
Left 0 1 (8.3%) 0 1 (8.3%) 
Bilateral 0 0 0 0 
Total 0 1 (8.3%) 0 1 (8.3%) 
Ocular symptoms were uncommon in fungus ball. Only 1 (8.3%) patient had 
decreased vision and pain of 1 week duration. 
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Table 3. Ophthalmological examination   (n=12) 
 Proptosis Impaired 
vision 
EOM 
restriction 
Optic 
Atrophy 
Papilloedema 
Right 0 0 0 0 0 
Left 0 1 (8.3%) 1 (8.3%) 1 (8.3%) 0 
Total 0 1 (8.3%) 1 (8.3%) 1 (8.3%) 0 
 
1 patient had impaired  vision, restriction of extraocular movements and optic 
atrophy. 
 
Table 4. Radiology    (n=12) 
 
 
2 (16.6%) patients had erosion of the lamina papyracea and 1 had intraocular mass 
(8.3%) on CT scan. 
 
Patients with invasive fungal rhinosinusitis were compared with those 
with non invasive  fungal rhinosinusitis and tests of significance were 
performed to see whether there was any significant difference in terms 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Right 1(8.3%) 0 0 0 0 0 
Left 0 0 0 0 0 0 
Bilateral 1(8.3%) 0 0 1(8.3%) 0 0 
Total 2 (16.6%) 0 0 1(8.3%) 0 0 
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of orbital involvement. Orbital involvement was considered as clinical 
and radiological involvement. 
Comparison between invasive fungal rhinosinusitis and non invasive 
fungal rhinosinusitis  
 
 
Table 1. Ophthalmic  symptoms                             
 Periorbital 
Swelling 
Decreased 
vision 
Diplopia Periorbital
Pain 
Invasive 
(n=34) 
25(73.5%) 20(58.8%) 15(44.1%
) 
21(61.8%) 
Non invasive 
(n=66) 
8(12.1%) 3(4.5%) 1(1.5%) 5 (7.6%) 
P value .000 .000 .000 .000 
 
Periorbital swelling and pain, decreased vision and diplopia were significantly 
more in patients with invasive fungal rhinosinusitis as compared to patients with 
non invasive fungal rhinosinusitis. 
Table 2. Ophthalmological examination    
 Proptosis Impaired 
vision 
EOM 
restriction 
Optic Atrophy/ 
Papilloedema 
Invasive 
(n=34) 
21(61.8%) 18(52.9%) 20(58.8%) 16 (47.1%) 
Non invasive 
(n=66) 
6(9.1%) 4 (6.1%) 3(4.5%) 2 (3%) 
P value .000 .000 .000 .000 
 
Proptosis, impaired vision, ophthalmoplegia and optic atrophy were significantly 
more in invasive as compared to non invasive fungal rhinosinusitis. 
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Table 3.Radiology 
 
Radiologically, erosion floor of orbit and optic nerve compression were 
significantly more in invasive compared to non invasive fungal rhinosinusitis. 
There was no significant difference in erosion of lamina papyraceae, erosion of the 
roof of orbit, intra ocular mass and intra ocular muscle involvement between 
patients with invasive and patients with non invasive fungal rhinosinusitis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Lamina 
papyracea 
erosion 
Roof of 
orbit 
erosion 
Floor of 
orbit 
erosion 
Intra ocular 
mass 
Intra ocular 
muscle 
involvement 
Optic nerve 
compression
Invasive 
(n=34) 
13(38.2%) 3(8.8%) 5(14.7%) 7(20.6%) 5(14.7%) 4(11.8%) 
Non 
invasive 
(n=66) 
21(31.8%) 3(4.5%) 2(3%) 13(19.7%) 3(4.5%) 1(1.5%) 
P value .521 .406 .043 .916 .117 .044 
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DISCUSSION 
 
  Orbital involvement is clinically apparent in most cases of fungal sinusitis 
and proper evaluation of ocular function should be part of the evaluation of the 
affected patient. The various aspects of evaluation for orbital involvement include 
clinical assessment for proptosis, periorbital pain and swelling, diplopia, loss of 
visual acuity, fields, restriction of ocular movements, fundus examination and 
radiological assessment. While in most instances clinical involvement mirrors the 
degree of radiological involvement of the orbit, in certain rapidly progressive cases 
of fungal sinusitis such as acute invasive fungal sinusitis, orbital symptoms may be 
disproportionate to the degree of orbital invasion seen  radiologically. In the 
present study we have specifically looked for orbital involvement in both invasive 
and non-invasive fungal sinusitis and found a number of differences between the 
two categories.  
 Our finding that orbital involvement in non-invasive fungal sinusitis is 
infrequent similar to that of other studies.  In a large series of 82 patients with 
AFRS, Marple et al26, found an overall incidence of ocular findings to be 18.3%. 
Telecanthus was the most common symptom (7.3%) followed by diplopia. 
Three(3.7%) patients had visual loss. Similarly, Cody et al found that 17% of a 
series of 42 patients with AFRS had orbitalinvolvement. However they did not 
specify what the symptoms and signs were. In the present study, we found that the 
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overall orbital involvement was 14.8%. Eight patients(14.8%) had periorbital 
swelling, 1 had diplopia and 4 (7.4%) presented with periorbital pain. 
 Proptosis and periorbital swelling are common features of AFRS and have 
been reported in as many as 50% of patients in some series (Manning et al). In our 
study, the most common orbital sign on examination was proptosis (11.1%). 
Proptosis resolves with surgical debridement of the sinuses and postoperative oral 
steroid therapy(Chang et al). 
 Visual loss is an unusual feature of non invasive fungal sinusitis. The 
prevalence of visual loss in some series  varies from 3-10%. (Marple et al; 
Manning et al). Visual loss in AFRS is most often due to pressure by the 
expanding sinuses on the optic nerve. It is therefore reversible and often resolves 
with appropriate decompression along with oral steroid therapy.  In our study, we 
encountered 2 ( 3.7%) patients presenting with decreased vision. One had bilateral 
nasal obstruction and watery nasal discharge of 6 month’s duration and decreased 
vision on the left side of 8 day’s duration. She was taken up for endoscopic sinus 
surgery and post operatively, was started on systemic steroids. On the second post 
operative day, her vision improved from negative perception of light to counting 
fingers at 20 metres. Two weeks after surgery her vision further improved. Our 
second patient with visual loss presented with bilateral proptosis and she 
underwent bilateral endoscopic sinus surgery and orbital decompression followed 
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by systemic steroids. Dunlop et al33 reported 1 case of allergic fungal rhinosinusitis 
presenting with visual loss who was treated with debridement of sinuses and 
antibiotics initially without improvement. She was subsequently started on 
systemic corticosteroids and rapidly improved.  
 Visual loss due to fungus ball is even less common.                     
In our study of patients with fungus ball, 1 patient (8.3%) presented with orbital 
apex syndrome with loss of vision and restriction of extraocular muscle 
movements. The patient was a 72 year old man with well controlled diabetes 
mellitus (HBA1C – 7.6). He underwent endoscopic sinus surgery and orbital 
decompression and was found to have a polypoidal mass in the posterior ethmoids 
and sphenoid sinus. He was started on the Inj. Amphotericin B which was 
subsequently changed to Voriconazole (because of resistance to Amphotericin B). 
There was  rapid progression of symptoms and he died 4 days post operatively of 
pneumonia. The only other case report of fungus ball causing visual loss was that 
of Thiagalingam et al34 who reported a case of fungus ball in the sphenoid sinus by 
Pseudallescheria boydii presenting with orbital apex syndrome. The patient was a 
92 year old man who presented with painless loss of vision of 3 day’s duration. He 
was started on Inj. Penicillin and oral Voriconazole. He underwent left endoscopic 
sphenoidotomy and was found to have a mycetoma in sphenoid sinus. Here again, 
the patient died 1 month after surgery due to unrelated causes. 
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 Restriction of extraocular muscle movement is also an uncommon feature of 
orbital involvement in AFRS. Only 2 patients in our series were affected, similar to 
the few numbers seen in other series 26. The reason for this is that restriction of 
muscle movement is purely mechanical unlike in patients with invasive sinusitis 
where actual invasion of the muscle may occur. A rare presentation of AFRS is 
subperisoteal abscess formation as reported by Meyer and Nagi20. The patient 
described underwent sinus drainage followed by left anterior orbitotomy and 
drainage of the abscess that contained yellowish fluid. Culture of this fluid showed 
Aspergillosis. 
 Radiological evidence of orbital erosion in noninvasive fungal sinusitis is 
seen more commonly than clinical involvement. In most patients this is manifested 
as erosion of the lamina papyracea and intraocular mass. As the ethmoid sinus is 
the most commonly involved sinus in AFRS, erosion of the lamina papyraceae 
may occur with expansion of the contents of the sinuses into the orbit. In the 
present series we noted lamina papyraceae erosion in upto 27.8% of patients and 
an intraocular mass in 18.5%. Nussenbaum et al24 in a retrospective study of 142 
patients with allergic fungal sinusitis, found that 21(15%) of patients had orbital 
involvement on CT scan. Ghegan et al21  in a study of 27 patients found that 15 
(56%) had skull base or orbital erosion. They did not specify exactly how many 
patients had purely orbital erosion. Manning et al14 in a study of 10 patients 
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reported that 4 (40%) patients had orbital involvement. None of these studies 
specify which part of the orbit was involved. Erosion of the floor of orbit (1.8%), 
intraocular muscle involvement(3.6%) and optic nerve compression(5.4%) were 
less commonly seen radiological features in our cases.We could not find any 
reports mentioning bony erosion in patients with fungus ball. In our study, of the 
12 patients with fungus ball, 2(16.7%) had erosion of the lamina papyracea and 1 
had intra ocular mass. 
 Overall, patients with non invasive fungal sinusitis in the present study have  
a lesser degree of orbital involvement than those with invasive fungal sinusitis. Of 
the 8 (12.1%) of patients with orbital symptoms, periorbital swelling followed by 
periorbital pain, decreased vision and diplopia were the symptoms complained of. 
Proptosis was the most common sign. Radiological involvement of the orbit was 
also less at 25.7 %(17 patients).  These findings are similar to other reports 
(Manning et al, Nussenbaum et al). 
  Unlike noninvasive fungal sinusitis, orbital involvement in invasive fungal 
rhinosinusitis is well documented. Nithyanandam et al19 in a study of 34 patients 
with mucormycosis found that 23 (68%) had orbital involvement clinically. Loss 
of vision was the most common symptom(67.6%) followed by diplopia(29.4%). 
On examination, 23(67.6%) patients had ptosis and ophthalmoplegia and 
14(41.2%) had proptosis. 9 patients(26.5%) underwent orbital exenteration and 
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11(32.4%) patients died. In our study, of the 34 patients with invasive fungal 
rhinosinusitis, the most common symptom was periorbital swelling (67.6%) 
followed by periorbital pain (61.7%), decreased vision (58.8%) and diplopia 
(44.1%). The commonest orbital signs on examination were proptosis and 
ophthalmoplegia(61.8%) followed by impaired vision (53%). 14 patients (41.2%) 
had optic atrophy on ophthalmoscopy and 2 (5.8%) had papilloedema. 12 (35.3%) 
patients underwent orbital exenteration and  8 (23.5%) patients died.  
          Bhansali et al35 in a study of 35 patients of mucormycosis with diabetes 
mellitus found that 89% had ophthalmoplegia, 83% had proptosis and 80% had 
loss of vision. The most common symptom was periorbital swelling(66%) 
followed by periorbital pain (43%) In our study, the most common predisposing 
condition was uncontrolled diabetes mellitus (68%). 
          Ferry et al36 in a report of 16 cases found that 6 (37.5%) had proptosis and 4 
(25%) had visual loss at initial presentation. In the series of 114 patients by Yohai 
et al37 18 (16%) had proptosis, 34 (30%) had visual loss and 33 (29%) had 
ophthalmoplegia. Overall 80 patients (70%) had orbital involvement. In our series 
we found that 67.6% patients had orbital involvement clinically. Proptosis and 
visual loss were seen in a higher number of patients in our study. 
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          Gillespie et al17 reported a series of 25 cases of acute fulminant fungal 
rhinosinusitis, of whom 16 (64%) had periorbital pain and swelling and 7 (28%) 
had decreased visual acuity or ophthalmoplegia as the presenting complaint.  
          CT scans of patients with invasive fungal rhinosinusitis are non specific and 
do not correlate well with surgical and pathologic findings.17  In the study by 
Nithyanandam et al19 of 34 patients with mucormycosis, 18 patients had orbital 
changes on CT scan which included intraocular muscle involvement, and minimal 
obliteration of fat shadow at the orbital apex. They do not mention the exact 
site/frequency of radiological  erosion. Of the 35 patients in the series reported by 
Bhansali et al 35 28(80%) had CT findings of orbital erosion. The authors do not 
mention the exact site of erosion. In Bhadada et al29 report of 6 cases of patients 
with mucormycosis, 5 (83.3%) patients had orbital erosion. They also do not 
mention which portion of the orbit was involved. 
          In the present study we found that 13 (38.3%) patients had CT scan evidence 
of lamina papyracea erosion, 7 (20.6%) patients had intraocular mass,3 (8.8%) had 
erosion of roof of orbit, 5 (14.7%) had erosion of floor of orbit and involvement of 
intraocular muscle. Further, orbital symptoms and signs like proptosis, impaired 
vision, diplopia, pain and optic atrophy/papilloedema were significantly more in 
patients with invasive as compared to patients with non invasive fungal 
rhinosinusitis. Radiologically, erosion of  floor of orbit and optic nerve 
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compression were significantly more in invasive compared to non invasive fungal 
rhinosinusitis.  
          A literature search did not reveal any studies comparing the orbital 
involvement in acute invasive and chronic granulomatous and chronic invasive 
fungal rhinosinusitis. In our study, we found that there was not much difference in 
orbital symptoms between patients with chronic invasive and chronic 
granulomatous fungal rhinosinusitis and acute invasive fungal rhinosinusitis. 
However, optic atrophy and papilloedema were significantly  more frequently seen  
in chronic invasive  and chronic granulomatous invasive fungal rhinosinusitis as 
compared to acute invasive fungal rhinosinusitis. Radiologically,  intraocular 
muscle involvement and optic nerve compression were significantly more in 
chronic invasive  and chronic granulomatous invasive fungal rhinosinusitis as 
compared to acute invasive fungal rhinosinusitis. 
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CONCLUSION 
           In conclusion, orbital involvement is much more common in occurrence in 
invasive fungal sinusitis compared to non invasive fungal sinusitis. Clinical and 
endoscopic examination is an essential part of assessing orbital involvement. 
Radiological findings in invasive fungal sinusitis evidently bear no correlation with 
clinical findings. Indeed, despite the high prevalence of ocular involvement in 
patients with invasive fungal sinusitis, the radiological findings are often 
unremarkable. A high index of suspicion and early biopsy and fungal culture 
testing in suspected patients helps early identification and planning of subsequent 
management. 
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Appendix A                 
Informed Consent form 
 
Title: Orbital involvement in Fungal Sinusitis 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
 (i) I confirm that I have read and understood the information sheet dated _________ for 
the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further research 
that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
access. However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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Appendix B 
PROFORMA 
Serial Number : 
Name : 
Age/Sex :                                       Hospital number : 
Occupation :                                 Contact number : 
Address: 
Admitting unit : 
DOA:                                DOS:                            DOD: 
Clinical Diagnosis  
Acute (Fulminant) invasive fungal sinusitis, Chronic invasive fungal sinusitis, 
Granulomatous invasive fungal sinusitis, Allergic fungal sinusitis, Fungal Ball, 
Entomophthoromycosis 
Clinical History 
• Sinonasal symptoms  
¾ Nasal Obstruction - Present/Absent 
Side Duration 
  
¾ Nasal Discharge - Present/Absent 
Type Side  Duration 
   
 
¾ Sneezing -  Present/Absent 
¾ Post Nasal discharge - Present/Absent 
• Eye symptoms                     Right                                               Left 
Swelling of eye   
Decreased Vision   
Diplopia   
Pain eye   
 
• Headache, Fever, LOC, Seizures, Asthma/Atopy, Aspirin hypersensitivity 
Co-morbidities 
60 
 
• DM - Controlled/Uncontrolled, Haematological diseases,Transplant,Renal 
diseases,Others 
Current drug use 
• Immunosuppressant, Systemic/Topical steroid 
Prior Sinus Surgery – Y/N 
Date Details 
  
Examination 
• Rigid Nasal Endoscopy –       Right                                             Left 
Inferior Turbinate   
Floor of Nose   
Inferior Meatus   
Nasopharynx   
Middle Turbinate   
Middle Meatus   
Sphenoethmoidal Recess   
Roof of nose   
Septum   
Nasal Cavity   
• Eye –                                        Right                                              Left 
Visual Acuity   
Colour Vision   
Automated Perimetry   
Extra ocular motility   
Ophthalmoscopy   
Investigations 
1.Radiology 
Region Right Left 
Sinuses Lund 
Mackay 
Hyper 
dense 
areas 
Bone 
Erosion
Lund 
Mackay 
Hyper 
dense 
areas 
Bone 
Erosion 
Maxillary Sinus       
Anterior Ethmoid 
Sinus 
      
Posterior Ethmoid       
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Sinus 
Frontal Sinus       
Sphenoid Sinus       
OMC       
 
Region Right 
 
Left 
Nasal Cavity   
Nasopharynx   
Septum   
 
Region     Right          Left 
Erosion of Roof of Ethmoid   
Erosion of Cribriform Plate   
Erosion of Lamina Papyraceae   
Erosion of Roof of Orbit   
Erosion of Floor of Orbit   
Optic Nerve compression   
Intraocular mass/abscess   
Intraocular muscle involvement   
Intracranial extension – extradural   
Intracranial extension – intradural   
2.Mycology – 
Date Fungal Smear 
(KOH) 
Fungal Culture 
   
3.HIV, Au.  
4.Random Blood Sugar 
    Fasting/Post prandial 
    HbA1C 
5.Skin Allergy test 
6.Fungal Specific Ab 
7.IgE 
8.Histopathology – 
• Acute Invasive 
Fungal invasion of 
 Mucosa/Submucosa/Blood vessels/Bone 
    Yes     No 
Inflammatory exudates – Acute/Chronic   
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cells 
Tissue necrosis   
Thrombosis   
Fibrinoid necrosis   
Fibrosis   
Vasculitis   
• Chronic Invasive 
Necrosis Yes No 
Fibrosis   
Vasculitis   
Fungal hyphae in  
Mucosa/Submucosa/Blood vessels/Bone 
Septate/Aseptate 
  
Chronic inflammatory infiltrate   
 
• Chronic Granulomatous Invasive 
Granuloma Yes No 
Fibrinoid Necrosis   
Vasculitis   
Fungal hyphae in  
Mucosa/Submucosa/Blood vessels/Bone  
Septate/Aseptate 
  
Chronic inflammatory cells   
 
• Entomophthoromycosis 
Granuloma   
Fungal hyphae –Septate/Aseptate   
Splendor Hoeppli phenomenon   
Inflammation Acute/Chronic   
Tissue necrosis   
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• Allergic Fungal Sinusitis 
Specimen (Mucosa & Allergic mucin) sent 
as 
Single Separate 
ALLERGIC MUCIN 
Layered eosinophilic mucus   
Necrotic eosinophils    
Charcot leyden crystals   
Fungal hyphae – Septate/Aseptate   
MUCOSA 
Edema   
Chronic inflammatory cells   
Eosinophils   
Invasion/Necrosis/Granuloma   
• Fungal Ball 
Dense accumulation of fungal 
filaments 
  
Chronic inflammation   
Invasion   
Allergic mucin   
Treatment 
• Medical treatment 
Drug Dosage Start date End date Duration 
     
• Surgical treatment 
Date Operation/Procedure 
& Sinuses involved 
     M  E  S  F 
Operative findings 
  Polyps            AM               Bone erosion       
Others 
  M  E  S  F      M  E  S  F        M  E  S  F          M  E  
S  F 
 
 
64 
 
• Post operative visits (1 week) 
Date             RNE findings Others 
   
Follow up 
• Clinical symptoms 
Date Symptoms 
NB                 ND                 Allergic                    
Other 
RNE  
Grading 
   
• Fungal Culture 
Date Report 
  
 
• Outcome - Recurrence/ Exacerbation, Stable, Cure 
Death date –  
Cause of death : Fungal sinusitis related/ Non Fungal sinusitis related 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
